Cannabis Law Report

AUGUST 19, 2019

Recently, three British MPs went to Canada on a fact-finding cross-party trip to consider the effects of a more relaxed regulatory environment in respect of cannabis. To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. Authors – Carolyn E.

Environment 45

Environment Food Seed-To-Sale Medicine 45

Veriheal

APRIL 24, 2023

The body of scientific evidence supporting the use of psychedelics in the treatment of PTSD, addiction, major depressive disorder, and various other mental health disorders continues to grow. However, despite the mounting data supporting their efficacy, the precise mechanism of action for psychedelics remains a mystery.

Research and Development 77

Research and Development Treatment Conditions Therapy 77

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

JANUARY 4, 2022

Medical marijuana treatment centers like Gold Leaf are the only businesses currently authorized to cultivate, process, and dispense low-THC cannabis and medical marijuana in Florida. Agrify brings data, science, and technology to its customers for unparalleled control over cultivation and extraction. BILLERICA, Mass.,

Extraction 52

Extraction Cultivation Programs Data 52

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. FSA/Dep Care. Pet Insurance.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

JUNE 9, 2021

MAPS is committed to bringing these healing modalities to the world and providing them in such a way that communities that most need mental health resources have access to them. MAPS strives to continually improve upon the supportive, equitable, and accessible work environment. outside counsel).

Research and Development 76

Research and Development Compliance Compliance Education 76

Cannabis Law Report

AUGUST 12, 2021

To grow cannabis, a person must hold a license from the State Institute for Drug Control for the cultivation of cannabis for medical use Authorization for the handling of addictive substances and preparations for activities related to the treatment of cannabis is also required.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Veriheal

DECEMBER 27, 2022

The subjective nature of self-reported data can plague research. And although most countries criminalize psychedelic use, gaining insight into how they work could contribute to the development of alternative treatments. To combat this, researchers of this new study quizzed participants in an actual, knowledge-based test.

Research and Development 95

Research and Development Therapy Consumption DEA 95

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. Steve Barbera is an accomplished cross-functional leader in the healthcare industry, with over 20 years of experience in the development and implementation of complex market access strategies including health policy, pricing and reimbursement, contracts and coding. Sesen Bio, Inc.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

NORML

MAY 24, 2019

At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives.

Marijuana 103

Marijuana Education Advocacy Legislation 103

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Entrepreneurs and businesses leverage this data to navigate the competitive landscape, ensuring they meet market demands.

Marijuana 52

Marijuana Dispensary Research and Development Supply Chain 52

Cannabis Law Report

DECEMBER 21, 2021

The rapid increase in the volume of enterprise data and growing automation of business processes across several end-use industries such as retail, manufacturing, healthcare, and transportation are expected to drive the demand for business software and services over the forecast period. billion in 2020 (Grandview Research). from 2021 to 2028.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. The Environment Testing business experienced very strong volumes across most geographies in Europe, with continued market share gains. 6-PPD Quinone) testing and dioxin testing.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

FEBRUARY 17, 2020

The Committee will convene telephonically and in-person bimonthly to develop ways and methods to expand patient access and affordability, increase innovation and technology within the cannabis industry, and to make recommendations to the Legislature and the Department of Health’s Office of Medical Marijuana Use (OMMU).

Dispensary 76

Dispensary Patients Agriculture Conditions 76

CannaTech

MAY 16, 2019

This revolutionary storage device maintains optimal conditions for cannabis freshness and potency, and makes monitoring, tracking, dispensing, and procuring medical cannabis accessible to everyday patients. This important data can, in turn, be leveraged to improve course of treatment, analyze usage patterns, and track product quality.

Data 13

Data Collective Consumption Treatment 13

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to provide appropriate research data. Methods and practices related to odor mitigation, sanitation and airflow, and employee safety in cultivation environments. Criterion 5.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to provide appropriate research data. Methods and practices related to odor mitigation, sanitation and airflow, and employee safety in cultivation environments.

Law 40

Law Marijuana Education Cultivation 40

Veriheal

AUGUST 31, 2021

His device not only provides an accessible option for cannabis users who are moving away from smoking but also opens up the opportunity for unique experiences with cannabis in the same way Starbucks revolutionized how people drink coffee. . Camille Elliott. School: Villanova University. Major/Program: Nursing. Sheldon Padgett.

Research and Development 116

Research and Development Supply Chain Programs Education 116

The Cannigma

JUNE 21, 2021

To address these limitations, the new work used data from 831 students (aged 12-21 years at baseline) gathered as part of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) study. These data were analyzed in a model using age, sex, race, parental education, the previous year’s substance use as covariates. .

Sleep 61

Sleep Data Patients Chronic Pain 61

Cannabis Law Report

JUNE 3, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. Self-starter who is proactive and can work independently.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

MARCH 1, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. Roles and responsibilities. Coordinate with outside counsel.

Compliance 52

Compliance Compliance Legalization Research and Development 52

Cannabis Law Report

MARCH 1, 2022

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. Self-starter who is proactive and can work independently.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

DECEMBER 15, 2021

In 2021, atai has achieved many major milestones, for example the promising phase 2a data for its schizophrenia drug RL-007 or the Phase 2b readout of Compass Pathways , of which atai owns 22.6% 4) Digital & Data. as of its last public filing. It is imperative to me to be in this journey for the long run.

Research and Development 52

Research and Development Data History Patients 52

Cannabis Law Report

OCTOBER 2, 2021

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. Self-starter who is proactive and can work independently.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

CannaTech

FEBRUARY 25, 2019

The company’s latest developments include hydrogel products for the treatment of pain, acute dermatological diseases, and inflammatory bowel diseases. Brainose : An aerosolized nose-to-brain delivery system for cannabis-derived therapeutics specialized for the treatment of central nervous system (CNS) indications.

Research and Development 85

Research and Development Hybrid Treatment Strains 85

Cannabis Law Report

JANUARY 10, 2020

This continues to create challenges for marijuana businesses, including access to the payment and banking systems. xiii Dispensary counts are estimated using current business licensing data from Colorado Department of Revenue Enforcement Division. The data can be found here: [link]. The data can be found here: [link].

Banking 59

Banking Marijuana Collective Recreational 59

The Cannigma

MARCH 2, 2022

Hear the tale of how Anthony came to work in the cannabis space, telling the stories of cannabis brands and making them accessible to non-users. We’ve got a segment with Americans for Safe Access, talking a little bit about regulation and some current affairs. AR: You can access the full report at safeaccessnow.org/sos.

Wellness and Beauty 52

Wellness and Beauty Cannabis Media Patients 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Business 52

Business Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Retail 52

Retail Data Safety Cannabinoids 52

SpeedWeed

JULY 31, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Legalization 52

Legalization Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Data 52

Data Safety Cannabinoids Cannabis 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Dispensary 52

Dispensary Data Safety Cannabinoids 52

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

SEPTEMBER 19, 2019

Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. Yet, access to legal medicinal marijuana remains extremely limited. GW Pharmaceuticals ?and

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018.

Law 40

Law Seed-To-Sale Hemp Recreational 40